TACR2
Substance-K receptor
Also known as: NK2R, NK2R_HUMAN, NKNAR, SKR, TAC2R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21452
- Gene
- TACR2
- Ensembl
- ENSG00000075073
- Chromosome
- 10
- Canonical length
- 398 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene belongs to a family of genes that function as receptors for tachykinins. Receptor affinities are specified by variations in the 5'-end of the sequence. The receptors belonging to this family are characterized by interactions with G proteins and 7 hydrophobic transmembrane regions. This gene encodes the receptor for the tachykinin neuropeptide substance K, also referred to as neurokinin A. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>P21452|TACR2
1 MGTCDIVTEA NISSGPESNT TGITAFSMPS WQLALWATAY LALVLVAVTG NAIVIWIILA
61 HRRMRTVTNY FIVNLALADL CMAAFNAAFN FVYASHNIWY FGRAFCYFQN LFPITAMFVS
121 IYSMTAIAAD RYMAIVHPFQ PRLSAPSTKA VIAGIWLVAL ALASPQCFYS TVTMDQGATK
181 CVVAWPEDSG GKTLLLYHLV VIALIYFLPL AVMFVAYSVI GLTLWRRAVP GHQAHGANLR
241 HLQAMKKFVK TMVLVVLTFA ICWLPYHLYF ILGSFQEDIY CHKFIQQVYL ALFWLAMSST
301 MYNPIIYCCL NHRFRSGFRL AFRCCPWVTP TKEDKLELTP TTSLSTRVNR CHTKETLFMA
361 GDTAPSEATS GEAGRPQDGS GLWFGYGLLA PTKTHVEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TACR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 134 nTPM
Expression across tissuesHPA
Tissue
- colon: 134 nTPM
- urinary bladder: 35 nTPM
- smooth muscle: 31 nTPM
- stomach: 27 nTPM
- small intestine: 23 nTPM
- fallopian tube: 19 nTPM
Single-cell type
- smooth muscle cells: 44 nCPM
- tuft cells: 12 nCPM
- retinal horizontal cells: 10 nCPM
- cardiomyocytes: 9.7 nCPM
- epicardial cells: 6.8 nCPM
- hepatic stellate cells: 6.5 nCPM
Immune cell
- intermediate monocyte: 1.3 nTPM
- myeloid DC: 0.6 nTPM
- non-classical monocyte: 0.6 nTPM
- classical monocyte: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- basophil: 0.2 nTPM
Brain region
- hippocampal formation: 14 nTPM
- cerebral cortex: 14 nTPM
- cerebellum: 14 nTPM
- amygdala: 13 nTPM
- basal ganglia: 13 nTPM
- white matter: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- intestine smooth muscle contraction
- muscle contraction
- negative regulation of luteinizing hormone secretion
- operant conditioning
- phospholipase C-activating tachykinin receptor signaling pathway
- positive regulation of acetylcholine secretion, neurotransmission
- positive regulation of flagellated sperm motility
- positive regulation of monoatomic ion transport
- positive regulation of smooth muscle contraction
- positive regulation of uterine smooth muscle contraction
- positive regulation of vascular permeability
- prolactin secretion
- response to electrical stimulus
- tachykinin receptor signaling pathway
Molecular functions
- tachykinin receptor activity
- substance K receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TACR2 as an antibody target. Whether an autoantibody or antibody against TACR2 could matter depends on whether native TACR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TACR2 is annotated at the cell surface, where native TACR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TACR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...